Phase II Trial Comparing 3 vs 4 Fractions of Brachytherapy for Cervical Cancer
This study is looking at two ways to give radiation therapy (brachytherapy) for locally advanced cervical cancer. You would receive either 3 fractions (doses) of 8 Gy each, or 4 fractions of 7 Gy each, which is the current standard treatment. The main goal is to see how many patients can successfully complete the 3-fraction treatment. To join, you must have cervical cancer and be planning to receive brachytherapy, be at least 18 years old, and be able to understand and sign a consent form. The study is currently unclear on its recruitment status.
- Study design
- This is a non-randomized clinical trial, meaning you would not be randomly assigned to a treatment group. It plans to enroll 41 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The proportion of patients receiving the 3-fraction regimen will be measured up to 8 months after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Elizabeth Kidd, MD · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Proportion of Patients Receiving 3-Fraction Brachytherapy RegimenUp to 8 months
Proportion of patients that underwent a 3 fraction brachytherapy regimen.